Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients
The gut microbiota plays a critical role in the anti-tumor immune response. There is increasing data showing that antibiotics (ATBs) change the composition of the gut microbiota and affect the efficacy of immune checkpoint inhibitors (ICIs). However, this is the first meta-analysis to evaluate the a...
Main Authors: | Xuan-Zhang Huang, Peng Gao, Yong-Xi Song, Yan Xu, Jing-Xu Sun, Xiao-Wan Chen, Jun-Hua Zhao, Zhen-Ning Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2019.1665973 |
Similar Items
-
Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Yue An, et al.
Published: (2020-06-01) -
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
by: Hisanaga K, et al.
Published: (2021-02-01) -
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
by: Hisanaga K, et al.
Published: (2021-07-01) -
Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients
by: Damir Vucinic, et al.
Published: (2024-03-01) -
Biomarkers of related driver genes predict anti-tumor efficacy of immune checkpoint inhibitors
by: Shuai Jiang, et al.
Published: (2022-09-01)